DCGI approves radiological and nuclear emergency drugs developed by DRDO
JNS: Drugs Controller General of India has issued permits to Scott-Edil Pharmacia Ltd in Himachal Pradesh and Skanttr Lifescience in Gujarat to produce and sell Prussian blue insoluble formulations. The WHO lists it as a radiological and nuclear…
Coronavirus vaccines for 5-12 years children
JNS: Drugs Controller General of India (DCGI), India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children, aged between 5 to 12 years. Corbevax was approved…
DCGI grants EUA to Corbevax for children between 12-18 years
JNS: Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group. With the emergency use approval to Corbevax, the country has now two Covid-19 vaccines for…
Bharat Biotech gets nod for Phase 3 trials of intranasal vaccine
JNS: The subject expert committee (SEC) of Drugs controller General of India (DCGI) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company had also sought approval from the SEC to use…
DCGI approves DNA-based vaccine ZyCoV-D (three-dose vaccine) for Emergency Use Authorization
JNS: Drug Controller General of India (DCGI) has given nod to ZyCoV-D vaccine— indigenous developed Zydus Cadila COVID-19 vaccine for Emergency Use Authorization. In a statement Ministry of Science and Technology said that it is the world’s first and…
Moderna gets government nod for EUA in India
JNS: The Drugs Controller General of India (DCGI), granted permission of the Emergency Use Authorisation (EUA) of Moderna’s COVID-19 vaccine in India on Tuesday. The DCGI, granted permission to Cipla (a Mumbai-based pharmaceutical company) to import…
2-DG drug for treatment of COVID-19 patients to be launched next week
JNS: DRDO’s drug 2-Deoxy-D-Glucose is expected to be launched next week for the COVID patients, informed an official on Friday. The drug has been developed by the Defence Research and Development Organisation, DRDO which recently got the approval for…
डीसीजीआई ने डीआरडीओ की दवा को कोरोना मरीजों पर आपातकालीन उपयोग की मंजूरी दी
जेएनएस। ड्रग्स कंट्रोलर जनरल ऑफ इंडिया (DCGI) ने रक्षात्मक अनुसंधान और विकास संगठन (DRDO) द्वारा विकसित दवा को कोरोनोवायरस रोगियों के इलाज के लिए आपातकालीन उपयोग की मंजूरी दी है। रक्षा मंत्रालय ने शनिवार को बताया कि दवा 2-डीऑक्सी-डी-ग्लूकोज पाउडर के रूप…
Sputnik V gets emergency use authorisation in India
JNS: India got third vaccine— Sputnik V, against Coronavirus, after Covishield (the Oxford-Astrazeneca vaccine manufactured by the Serum Institute of India) and Covaxin (manufactured by Bharat Biotech is developed in collaboration with the Indian Council…
Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine
JNS: Zydus Cadila Pharmaceuticals has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in COVID-19 patients, the company said in…